Hoffmann, Katrin
Milech, Nadia
Juraja, Suzy M.
Cunningham, Paula T.
Stone, Shane R.
Francis, Richard W. http://orcid.org/0000-0003-1580-7934
Anastasas, Mark
Hall, Clinton M.
Heinrich, Tatjana
Bogdawa, Heique M.
Winslow, Scott
Scobie, Marie N.
Dewhurst, Robert E. http://orcid.org/0000-0001-8441-4427
Florez, Laura
Ong, Ferrer
Kerfoot, Maria
Champain, Danie
Adams, Abbie M.
Fletcher, Susan http://orcid.org/0000-0002-8632-641X
Viola, Helena M.
Hool, Livia C.
Connor, Theresa
Longville, Brooke A. C.
Tan, Yew-Foon
Kroeger, Karen
Morath, Volker http://orcid.org/0000-0001-7636-0537
Weiss, Gregory A.
Skerra, Arne http://orcid.org/0000-0002-5717-498X
Hopkins, Richard M.
Watt, Paul M.
Article History
Received: 28 February 2018
Accepted: 6 August 2018
First Online: 22 August 2018
Competing Interests
: The research of K.H., N.M., S.M.J., P.T.C., S.R.S, R.W.F., M.A., C.H., T.H., H.M.B., S.W., M.N.S., R.E.D, L.F., F.O., M.K., D.C., T.C., B.A.C.L., Y-F.T., K.K., R.M.H., and P.M.W. was funded by Phylogica, a spin-off company from the Telethon Kids Institute. P.M.W. and R.M.H. are founders and current shareholders in Phylogica. P.M.W. has consulted with and advised Phylogica. N.M., P.T.C., S.R.S, M.A., H.M.B., and L.F. currently hold shares in Phylogica. The combined shareholdings declared by all co-authors are less than 1% of Phylogica shares. G.A.W. has consulted with Phylogica. S.F. and A.M.A. are inventors on two patents relating to DMD, both licensed to Sarepta Therapeutics through the University of Western Australia (“Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof” WO 2006/000057 and “Antisense Molecules and Methods for Treating Pathologies” WO 2011/057350). S.F. also acts as a consultant to Sarepta Therapeutics. A.S. is a shareholder of XL-protein GmbH. H.M.V., L.C.H. and V.M. declare no competing interests.